The Vaccinia virus gene, E3L, encodes a doublestrandedRNA [dsRNA]-binding protein. We hypothesizedthat, owing to the critical nature of dsRNA intriggering host innate antiviral responses, E3L-specificsmall-interfering RNAs siRNAs] should be effectiveantiviral agents against pox viruses, for whichVacciniavirus is an appropriate surrogate. In this study, we haveutilized two human cell types, namely, HeLa and 293T,one which responds to interferon [IFN]-β and the otherproduces and responds to IFN-β, respectively. The antiviraleffects were equally robust in HeLa and 293Tcells. However, in the case of 293T cells, several distinctfeatures were observed, when IFN-β is activatedin these cells. Vaccinia virus replication was inhibitedby 97% and 98% as compared to control infection inHeLa and 293T cells transfected with E3L-specific siRNAs,respectively. These studies demonstrate the utilityof E3L-specific siRNAs as potent antiviral agentsfor small pox and related pox viruses.

siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exert potent antiviral effects: Intersection with innate immune system

Nunnari G;
2006-01-01

Abstract

The Vaccinia virus gene, E3L, encodes a doublestrandedRNA [dsRNA]-binding protein. We hypothesizedthat, owing to the critical nature of dsRNA intriggering host innate antiviral responses, E3L-specificsmall-interfering RNAs siRNAs] should be effectiveantiviral agents against pox viruses, for whichVacciniavirus is an appropriate surrogate. In this study, we haveutilized two human cell types, namely, HeLa and 293T,one which responds to interferon [IFN]-β and the otherproduces and responds to IFN-β, respectively. The antiviraleffects were equally robust in HeLa and 293Tcells. However, in the case of 293T cells, several distinctfeatures were observed, when IFN-β is activatedin these cells. Vaccinia virus replication was inhibitedby 97% and 98% as compared to control infection inHeLa and 293T cells transfected with E3L-specific siRNAs,respectively. These studies demonstrate the utilityof E3L-specific siRNAs as potent antiviral agentsfor small pox and related pox viruses.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/552226
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact